DOI:
10.1055/s-00026982
Urologie Scan
LinksClose Window
References
Denys P, Le Normand L, Ghout I et al.
Efficacy and safety of low doses of onabotulinumtoxinA for the treatment of refractory idiopathic overactive bladder: a multicentre, double-blind, randomised, placebocontrolled dose-ranging study.
Eur Urol 2012;
61: 520-529
Access:
We do not assume any responsibility for the contents of the web pages of other providers.